Liposomal Irinotecan Hydrochloride

DRUG2 trials

Sponsors

Zhejiang Cancer Hospital, Hebei Medical University Fourth Hospital

Conditions

Esophageal Squamous Cell CarcinomaGastric Cancer

Phase 1

Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

Not yet recruitingNCT06491134

Hebei Medical University Fourth HospitalEsophageal Squamous Cell Carcinoma

Start: 2024-06-27End: 2028-02-28Target: 12Updated: 2024-07-08

Phase 2

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Not yet recruitingNCT06437678

Zhejiang Cancer HospitalGastric Cancer

Start: 2024-05-27End: 2026-02-28Target: 50Updated: 2024-05-31